Equities research analysts at StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Morgan Stanley reaffirmed an “equal weight” […]